Treatment Patterns Among Patients with EGFRm NSCLC Treated in the US Community Oncology Setting

被引：0

作者：

Nadler, E. ^{[1
]}

Pavilack, M. ^{[2
]}

Clark, J. ^{[3
]}

Espirito, J. ^{[3
]}

Fernandes, A. ^{[2
]}

机构：

[1] Texas Oncol Baylor Charles A Sammons Canc Ctr, US Oncol Hlth Informat & Internet Technol, Dallas, TX USA

[2] Astrazeneca, Hlth Econ & Outcomes Res, Gaithersburg, MD USA

[3] Mckesson Life Sci, Outcomes Res, The Woodlands, TX USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期

关键词：

NSCLC; EGFR; treatment patterns;

D O I：

10.1016/j.jtho.2019.08.1262

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1.16-36

引用

页码：S601 / S601

页数：1

共 50 条

[31] Botulinum Toxin Utilization, Treatment Patterns, and Healthcare Costs Among Patients with Spasticity or Cervical Dystonia in the US [J].

Hull, Michael ;

Anupindi, Vamshi Ruthwik ;

DeKoven, Mitchell ;

He, Jing ;

Bouchard, Jonathan .

ADVANCES IN THERAPY, 2023, 40 (09) :3986-4003

[32] Clinical Characteristics and Treatment Patterns Among Patients Diagnosed With Cluster Headache in US Healthcare Claims Data [J].

Choong, Casey K. ;

Ford, Janet H. ;

Nyhuis, Allen W. ;

Joshi, Shivang G. ;

Robinson, Rebecca L. ;

Aurora, Sheena K. ;

Martinez, James M. .

HEADACHE, 2017, 57 (09) :1359-1374

[33] Physician Patterns of Care in Patients with EGFR Mutation plus NSCLC: An International Survey into Testing and Treatment Choice [J].

Tischer, Bernd ;

Kim, Edward ;

Peters, Matthew ;

Hirsh, Vera .

JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) :S1199-S1200

[34] Clinical and treatment characteristics of patients treated with the first therapeutic oncology biosimilars bevacizumab-awwb and trastuzumab-anns in the US [J].

Jin, Ran ;

Mahtani, Reshma L. ;

Accortt, Neil ;

Lawrence, Tatiana ;

Sandschafer, Darcie ;

Loaiza-Bonilla, Arturo .

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13

[35] Osimertinib vs Standard of Care (SoC) EGFR-TKI as First-Line Treatment in Chinese Patients With EGFRm Advanced NSCLC [J].

Zhou, C. ;

Cheng, Y. ;

He, Y. ;

Li, W. ;

Zhang, H. ;

Zhou, Q. ;

Wang, B. ;

Liu, C. ;

Ramalingam, S. ;

Walding, A. ;

Saggese, M. ;

Wang, J. ;

Fan, M. ;

Wu, Y. .

JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) :S507-S508

[36] Real-world Treatment Patterns Among Patients With Colorectal Cancer Treated With Trifluridine/Tipiracil and Regorafenib [J].

Patel, Anuj K. ;

Duh, Mei S. ;

Barghout, Victoria ;

Yenikomshian, Mihran A. ;

Xiao, Yongling ;

Wynant, Willy ;

Tabesh, Majid ;

Fuchs, Charles S. .

CLINICAL COLORECTAL CANCER, 2018, 17 (03) :E531-E539

[37] Troponin Elevation and the Risk of Myocarditis among NSCLC Patients Treated with Immune Checkpoint Inhibitors [J].

Waissengrin, B. ;

Atta, B. Abo ;

Merimsky, O. ;

Shamai, S. ;

Waller, E. ;

Wolf, I. ;

Peerl, M. Laufer .

JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) :S340-S341

[38] Real-world risk assessment and treatment initiation among patients with myelofibrosis at community oncology practices in the United States [J].

Srdan Verstovsek ;

Jingbo Yu ;

Jonathan K. Kish ;

Dilan Paranagama ;

Jill Kaufman ;

Callan Myerscough ;

Michael R. Grunwald ;

Philomena Colucci ;

Ruben Mesa .

Annals of Hematology, 2020, 99 :2555-2564

[39] Real-world risk assessment and treatment initiation among patients with myelofibrosis at community oncology practices in the United States [J].

Verstovsek, Srdan ;

Yu, Jingbo ;

Kish, Jonathan K. ;

Paranagama, Dilan ;

Kaufman, Jill ;

Myerscough, Callan ;

Grunwald, Michael R. ;

Colucci, Philomena ;

Mesa, Ruben .

ANNALS OF HEMATOLOGY, 2020, 99 (11) :2555-2564

[40] A real-world comparative analysis of carfilzomib and other systemic multiple myeloma chemotherapies in a US community oncology setting [J].

Rifkin, Robert M. ;

Medhekar, Rohan ;

Amirian, E. Susan ;

Aguilar, Kathleen M. ;

Wilson, Thomas ;

Boyd, Marley ;

Mezzi, Khalid ;

Panjabi, Sumeet .

THERAPEUTIC ADVANCES IN HEMATOLOGY, 2019, 10 :1-10

← 1 2 3 4 5 →